Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Victoza, produced by Novo Nordisk, holds FDA approval for regulating blood sugar levels among individuals diagnosed with type ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

By analyzing two independent Chinese cohorts, researchers from the CAS' Shanghai Institute of Materia Medica and Xiangya ...

ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) disease, today ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a ...

Nov. 26, 2024 — The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP ... kidney tissue by demonstrating an undiscovered mechanism behind kidney development and a novel ...

“While most common adverse events were mild and gastrointestinal in nature consistent with the mechanism ... GIP, and glucagon – that is also being advanced quickly into phase 3.

Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...